Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 4 Neoplasms 4 Prostatic Neoplasms 3 Glioma 3 Glioblastoma 3 Uterine Cervical Dysplasia 2 Sarcoma 2 Breast Neoplasms 2 Atypical Squamous Cells of the Cervix 2 Astrocytoma 2 Xeroderma Pigmentosum 1 Triple Negative Breast Neoplasms 1 Trichothiodystrophy Syndromes 1 Squamous Intraepithelial Lesions 1 Spinal Cord Neoplasms 1 Sexuality 1 Pilonidal Sinus 1 Peritoneal Neoplasms 1 Pelvic Organ Prolapse 1 Ovarian Neoplasms 1 Oligodendroglioma 1 Neurofibroma 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Meningioma 1 Melanoma 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leiomyoma 1

Interventions

Paclitaxel 8 Hyperthermic Intraperitoneal Chemotherapy 6 Mitomycin 5 Cisplatin 5 Fluorouracil 4 Bevacizumab 4 Oxaliplatin 3 Leucovorin 3 Doxorubicin 3 Cytoreduction Surgical Procedures 3 Carboplatin 3 Blood Specimen Collection 3 sodium thiosulfate 2 pembrolizumab 2 Standard of Care 2 Laparoscopy 2 soluble LAG-3 protein, human 1 relacorilant 1 oregovomab 1 olaparib 1 nilotinib 1 liposomal doxorubicin 1 irinotecan sucrosofate 1 dehydroftorafur 1 avelumab 1 X-Rays 1 Topotecan 1 Taxes 1 Specimen Handling 1 Saline Solution 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Peritoneal Neoplasms × Restraint, Physical × 1 year × Clear all

NCT02823860 2025-12-19

BIG-RENAPE

Hospices Civils de Lyon

Phase NA Completed

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡